Release Date: 18/03/14 10:16 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 163.37KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%